Skip to main content
MDT
NYSE Life Sciences

美敦力OmniaSecure导管首获FDA批准用于高级心脏起搏

feedReported by dpa-AFX
Sentiment info
Positive
Importance info
7
Price
$86.505
Mkt Cap
$111.062B
52W Low
$79.55
52W High
$106.33
Market data snapshot near publication time

summarizeSummary

美敦力获得FDA批准，将其OmniaSecure除颤导管的适应症扩大至左束支（LBB）区域，用于传导系统起搏（CSP）和左束支优化的心脏再同步治疗（LOT-CRT）。这是一个重要的发展，因为它标志着OmniaSecure导管成为第一个获得LBB放置批准的除颤导管，并且直径最小。这种监管胜利加强了美敦力在心脏节律管理市场的竞争地位，提供了一种更接近心脏自然电活动的创新解决方案。该积极的产品新闻紧随公司最近宣布计划收购Scientia Vascular的消息，表明公司正在继续努力增强其医疗设备产品组合。投资者应该在未来财报中关注该扩大适应症的商业推广和收入贡献。

在该公告发布时，MDT的交易价格为$86.51，交易所为NYSE，所属行业为Life Sciences，市值约为$1110.6亿。 52周交易区间为$79.55至$106.33。 这则新闻被评估为积极市场情绪，重要性评分为7/10。 来源：dpa-AFX。

show_chartPrice Chart

Share this article

Copied!

feed MDT - Latest Insights

MDT
Apr 25, 2026, 12:34 PM EDT
Source: Reuters
Importance Score:
8
Medtronic's Sphere-9 Catheter for VT Earns FDA Breakthrough Device Designation
Sentiment: Positive
View Wiseek Article
MDT
Apr 23, 2026, 8:14 AM EDT
Source: Reuters
Importance Score:
8
US to Speed Up Medicare Payments for New Medical Devices, Cutting Reimbursement Wait Times to Two Months
Sentiment: Positive
View Wiseek Article
MDT
Apr 20, 2026, 7:50 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Medtronic Finalizes CathWorks Acquisition, Bolstering Cardiovascular Leadership
Sentiment: Positive
View Wiseek Article
MDT
Mar 27, 2026, 9:01 AM EDT
Source: Reuters
Importance Score:
7
FDA Clears Medtronic's Stealth Axis™ Surgical System for Cranial, ENT Procedures
Sentiment: Positive
View Wiseek Article
MDT
Mar 24, 2026, 4:43 PM EDT
Source: Wiseek News
Importance Score:
8
Medtronic Cuts FY26 EPS Guidance by Over 2% on MiniMed Flex Charge, Dilution
Sentiment: Negative
View Wiseek Article
MDT
Mar 24, 2026, 4:42 PM EDT
Filing Type: 8-K
Importance Score:
7
Medtronic Lowers FY2026 EPS Guidance by $0.12/Share Due to MiniMed Flex Launch Costs and IPO Dilution
Sentiment: Negative
View Wiseek Article
MDT
Mar 24, 2026, 9:25 AM EDT
Source: dpa-AFX
Importance Score:
7
Medtronic Secures Exclusive Distribution for FDA-Approved ViaVerte System, Bolstering Pain Portfolio
Sentiment: Positive
View Wiseek Article
MDT
Mar 23, 2026, 9:38 AM EDT
Source: dpa-AFX
Importance Score:
7
Medtronic's OmniaSecure Lead First to Win FDA Approval for Advanced Cardiac Pacing
Sentiment: Positive
View Wiseek Article
MDT
Mar 10, 2026, 6:45 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Medtronic to Acquire Scientia Vascular, Expanding Medical Device Portfolio
Sentiment: Neutral
View Wiseek Article
MDT
Mar 06, 2026, 12:11 PM EST
Source: Reuters
Importance Score:
8
Medtronic's MiniMed Unit Shares Drop 4.8% in Nasdaq Debut, Valued at $5.3 Billion
Sentiment: Negative
View Wiseek Article